Pathstone Family Office’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-231
| Closed | -$10K | – | 792 |
|
|
2020
Q2 | $10K | Buy |
+231
| New | +$10K | ﹤0.01% | 510 |
|
|
2019
Q3 | – | Sell |
-27,250
| Closed | -$732K | – | 609 |
|
|
2019
Q2 | $732K | Buy |
+27,250
| New | +$732K | 0.09% | 102 |
|
|
2019
Q1 | – | Sell |
-26,500
| Closed | -$713K | – | 882 |
|
|
2018
Q4 | $713K | Buy |
+26,500
| New | +$713K | 0.2% | 42 |
|